Martin Hensel

Martin is the Founder of SelfRx Media and editor-in-chief of Insulin Nation. He's a passionate about sharing knowledge with those affected by Diabetes.
Treatment of Type 1 Diabetes

PKvitality CGM K’Watch is Exciting

We spoke with PKvitality’s General Manager Minh Lê, and CGM consultant Tom Bishop. They shared their investor slide deck and…

Read More »
Living with Type 1 Diabetes

Wave a Wand to Improve T1D Awareness

We spoke with Sequilla who is 17, lives in Victoria BC, and has had T1D since she was 2½ years…

Read More »
Research of Type 1 Diabetes

Path to Better Clinical Trials for T1D Delay/Prevention

The Critical Path Institute (C-Path) is a catalyst in the development of new approaches including biomarkers and modeling and analysis…

Read More »
Treatment of Type 1 Diabetes

SGLT2 inhibitors are Promising Medications for T1D but Vigilance Required

This article was written with a lot of help from Brad, a clinical pharmacist and pharmacotherapy specialist working in a…

Read More »
Living with Type 1 Diabetes

The Complete Diabetes Cookbook

America’s Test Kitchen is passionate about cooking — discovering and sharing why recipes work and why they don’t — to…

Read More »
Research of Type 1 Diabetes

BCG Vaccine Shows Promising Signals of T1D Efficacy

We spoke with Denise Faustman, MD, Ph.D., Director of Immunobiology Massachusetts General Hospital, and Associate Professor of Medicine Harvard Medical School. …

Read More »
Treatment of Type 1 Diabetes

JDRF Open Protocol — Path to Better Future

In 2018, JDRF celebrated the first anniversary of its Open Protocol initiative to support the development of automated insulin delivery…

Read More »
Treatment of Type 1 Diabetes

MannKind is Fixing Foundations to Build a Big Future

Michael is a pharmacist by training and a turnaround expert with a strong record of healthcare innovation.  He described the…

Read More »
Research of Type 1 Diabetes

T1D Delay/Prevention in at-risk Children

We spoke with Pieter Rottiers, Ph.D., CEO of ActoBio Therapeutics. Genetic testing, combined with existing NIH TrialNet procedures, has shown…

Read More »
Research of Type 1 Diabetes

Sernova Cell Pouch Hopes to Improve Islet Transplant Success

Sernova is a regenerative medicine company located in London, Ontario. The corporation is led by President and CEO Dr. Philip…

Read More »
Living with Type 1 Diabetes

Gestational DKA in Nepal

We exchanged email with Basanta.   “My name is Basanta. I am a 32-year-old woman.  I am in Nepal now.…

Read More »
Living with Type 1 Diabetes

Yes, Screen your Children for Presymptomatic Diabetes!

We spoke with Marian Rewers, MD, Ph.D., Professor of Pediatrics & Medicine and Executive Director, Barbara Davis Center for Diabetes…

Read More »
Research of Type 1 Diabetes

JDRF bets that Pandion Can Help

We spoke with Anthony Coyle, Ph.D., Co-founder and CEO of Pandion Therapeutics which is located in Cambridge Massachusetts.  This interview was…

Read More »
Treatment of Type 1 Diabetes

Dexcom is Excited, and Best is yet to Come

How do you see CGM devices evolving? The foundation of our product development is that we want our products to:…

Read More »
Research of Type 1 Diabetes

Vaccine for T1D in Clinical Trials Soon

INTRODUCTION Virus infections have long been considered as a possible cause of type 1 diabetes. One virus group, enteroviruses (EVs),…

Read More »
Research of Type 1 Diabetes

Regrowth of Human Beta Cells for T1D and T2D

Effective Therapeutic Rate A combination of two drugs enhances the production of beta cells such that they proliferate at the…

Read More »
Treatment of Type 1 Diabetes

CGM Sensors are good and getting even better

CGM's are getting better.

Read More »
Living with Type 1 Diabetes

New T1D book: TESTED

Here is a good book for the new year!  It is sure to give you some great ideas on how…

Read More »
Living with Type 1 Diabetes

Are CBDs the Future of Pain Relief?

Bonita was born in Ft. Sill, Oklahoma and moved often as an ‘Army brat’. She was diagnosed with T1D at…

Read More »
Living with Type 1 Diabetes

Public School 504 Solution has National Appeal

Diabetes care within schools is not great Many schools are underfunded and cannot afford school nurses or use staffing services…

Read More »
Back to top button